MannKind reports loss but record revenue for Q3
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Atara shares drop after larger Q3 loss than expected
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Arcutis reports Q3 loss, but first product revenue
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Velocity picks up speed with revenue and income growth
Velocity Financial, a real estate finance company based in Westlake Village, reported increases in both revenue and net income for the third quarter, compared to a year earlier. Velocity’s net income grew to $10 million from $8 million, an increase of 24.4%, while its diluted earnings per share grew to 29 cents from 23 cents, Read More →
SRAX files past-due annual report, fights Nasdaq delisting
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Mixed earnings reports for banking and real estate companies
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Amgen income tops $2B in Q3
Thousand Oaks-based Amgen saw a slight decline in revenue for the third quarter of 2022, but a substantial increase in earnings helped the company beat analysts’ expectations and maintain its stock price. One of the largest biotechnology companies in the world, Amgen delivered net income of $2.1 billion, or $3.98 per share, in the third Read More →
